The UK reclaims a leading role in clinical research: What this means for medical device and IVD manufacturers
In recent years, the clinical research landscape in the United [...]
Post-Market Surveillance: A Swiss perspective on critical compliance gaps
We’ve previously highlighted how important post-market surveillance (PMS) is, not [...]
IVD Classification: What’s new in the latest MDCG 2020-16 Rev.4 guidance?
In March 2025, the Medical Device Coordination Group (MDCG) [...]
MHRA publishes its first monthly safety bulletin for medical devices and medicines
In March 2025, the UK’s Medicines and Healthcare products Regulatory [...]
Hemodialysis bloodlines shortage: FDA alert and clinical implications
The U.S. Food and Drug Administration (FDA) has recently issued [...]
Conditional CE certificates: A new pathway for faster market access?
Over the past few years, the medical device industry has [...]
Data integrity in medical device testing – A critical FDA concern
Why data integrity in medical device testing is more important [...]
AI and medical devices: The UK defines a new regulatory path
Artificial Intelligence is transforming the healthcare industry, providing increasingly sophisticated [...]
New recall procedures in Australia: what changes with PRAC?
March 5, 2025, marked a significant step forward in [...]
UK IVD Registration: Key Updates for Manufacturers with Expiring CE Certificates
New MHRA guidance on in vitro diagnostic (IVD) device registration [...]
